DECADRON-LA
DEXAMETHASONE ACETATE
Approval overview DECADRON-LA is listed in Drugs@FDA under application 016675 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient DEXAMETHASONE ACETATE Form and strength INJECTABLE;INJECTION - EQ 8MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MERCK Submission history Latest submission status date: 1996-03-01 00:00:00.
Structured Monograph
Clinical summary
Approval overview DECADRON-LA is listed in Drugs@FDA under application 016675 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DEXAMETHASONE ACETATE Form and strength INJECTABLE;INJECTION - EQ 8MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MERCK Submission history Latest submission status date: 1996-03-01 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.